Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: General

Eyes on Washington: Federal Health Care Grant Notification Service

Tuesday, July 28, 2015   (0 Comments)
Posted by: TCAA Staff
Share |

Eyes on Washington: Federal Health Care Grant Notification Service

 

Grant Opportunities for July 20, 2015 through July 27, 2015

 

Visit Holland & Knight online

  

New Federal Health Care Grant Opportunities Announced for:

·         Centers for Disease Control and Prevention (CDC)

·         US Army Medical Research Acquisition Activity (USAMRAA)

·         National Institutes of Health (NIH)

 

NON-NIH Funding Opportunity Announcements:

 

CDC: Research and Methods in Health Statistics

Funding Opportunity Number: RFA-SH-16-001

This initiative invites investigator-initiated research grant applications for projects involving the development and testing of statistical and survey methodology relevant to the conduct, analysis and reporting of health surveys and vital records. Existing NCHS data sets alone or in conjunction with other data sets may be used to develop and test new survey methodology, statistical analytical approaches or methods of displaying data. Individual stand-alone projects relevant to the collection, analysis, or display of data are acceptable under this announcement. The R03 mechanism is intended to support small research projects that can be carried out in a short period of time with limited resources. It can be used to support different types of projects including: secondary analysis of existing data; small, self-contained research projects; pilot and feasibility studies; development and testing of statistical and survey methodology; and the development and testing of new survey technology. This funding opportunity was announced on July 23, 2015. The application deadline is October 7, 2015. For more information, please visit CDC’s Full Funding Opportunity Announcement.

 

USAMRAA: DoD FY15 Peer Reviewed Alzheimer’s Military Risk Factors Research Award

Funding Opportunity Number: W81XWH-15-PRARP-MRFA

The intent of the FY15 Peer Reviewed Alzheimer’s Research Program (PRARP) Military Risk Factors Research Award (MRFA) is to facilitate high-impact, systematic, population-based research investigating the association between TBI and the subsequent development of AD. The research impact will benefit the military, Veteran, and civilian communities. Applications should describe how the association of TBI and subsequent AD will be characterized. Applications should carefully consider how their studies will characterize the cognitive and behavioral symptoms that result in functional impairments in the proposed cohort. Studies that use combinations of measures (e.g., neuropsychological assessments, imaging, genomics, and cerebral spinal fluid biomarkers) are encouraged. Applications that develop interdisciplinary teams or consortia as part of the support plan for executing the research are encouraged. This funding opportunity was announced on July 20, 2015. The application deadline is November 25, 2015. For more information, please visit USAMRAA’s Full Funding Opportunity Announcement.

 

USMRAA: DoD FY15 Peer Reviewed Alzheimer’s Convergence Science Research Award

Funding Opportunity Number: W81XWH-15-PRARP-CSRA

The Peer Reviewed Alzheimer’s Research Program (PRARP) Convergence Science Research Award (CSRA) mechanism was first offered in FY12. Since then, 92 CSRA applications have been received, and 22 have been recommended for funding. The intent of the FY15 CSRA is to support efforts to generate research resources, tools, or novel research efforts for researchers and/or practitioners in health sciences related to the PRARP’s mission. The research impact will benefit the military, Veteran, and civilian communities. The CSRA is open to Principal Investigators (PIs) at or above the level of Assistant Professor (or equivalent) from any field or discipline who seek to bring their expertise to address the PRARP’s mission. However, as part of the application, the PI should demonstrate that the study team has experience in both TBI and AD research. This funding opportunity was announced on July 20, 2015. The application deadline is November 25, 2015. For more information, please visit USAMRAA’s Full Funding Opportunity Announcement.

 

USAMRAA: DoD FY15 Peer Reviewed Alzheimer’s Quality of Life Research Award

Funding Opportunity Number: W81XWH-15-PRARP-QUAL

The intent of the research funded through the Peer Reviewed Alzheimer’s Research Program (PRARP) Quality of Life Research Award (QUAL) is to reduce the burden on affected individuals and caregivers, especially in the military and Veteran communities. The research impact will benefit the military, Veteran, and civilian communities. The QUAL is open to Principal Investigators (PIs) at or above the level of Assistant Professor (or equivalent) from any field or discipline who seek to bring their expertise to address the PRARP’s mission. However, as part of the application, the PI should demonstrate that the study team has experience in both TBI and AD research. This funding opportunity was announced on July 20, 2015. The application deadline is November 25, 2015. For more information, please visit USAMRAA’s Full Funding Opportunity Announcement.

 

USAMRAA: DoD Epilepsy Idea Development Award

Funding Opportunity Number: W81XWH-15-ERP-IDA

The ERP Idea Development Award (IDA) mechanism is being offered for the first time in FY15. The intent of the ERP IDA is to solicit research to understand the magnitude and underlying mechanisms of PTE, especially in Service members and Veterans while benefitting the civilian community. To this end, the ERP has identified research Focus Areas for FY15 by which the intent of this mechanism can be facilitated (see Section I.B., FY15 ERP Focus Areas). The ERP IDA award offers two levels of funding. Level I is intended to support investigator-initiated research that may be high-risk and/or high-gain. Level II is intended to support advanced studies that may be multidisciplinary in nature, and/or have multiple collaborators. Applications to either Level I or II should provide relevant preliminary data to support the application’s research hypothesis (or hypotheses). It is the responsibility of the Principal Investigator (PI) to select the funding level most appropriate to the proposed research. The IDA is open to Principal Investigators (PIs) at or above the level of Assistant Professor (or equivalent) from any field or discipline who seek to bring their expertise to address the ERP’s mission. However, as part of the application, the PI should demonstrate that the study team has experience in both TBI and epilepsy research. This funding opportunity was announced on July 21, 2015. The application deadline is November 24, 2015. For more information, please visit USAMRAA’s Full Funding Opportunity Announcement.

 

USAMRAA: DoD FY15 Reconstructive Transplant Research (RTR) Clinical Trial Award

Funding Opportunity Number: W81XWH-15-RTR-CTA

To meet the intent of the FY15 RTR award mechanisms, applicants must address one or more of the Focus Areas listed below. Immune system regulation, Improved access to reconstructive transplantation , Reconstructive transplantation rehabilitation, Graft surveillance – Clinical monitoring, Psychosocial issues associated with VCA. The RTR Clinical Trial Award (RTR CTA) mechanism is being offered for the first time in FY15. . The intent of the FY15 RTR CTA mechanism is to support clinical trials with the potential to have a major impact on improving the function, wellness, and overall quality of life for injured Service members and Veterans, their caregivers and family members, and the American public. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. This funding opportunity was announced on July 23, 2015. The application deadline is December 1, 2015. For more information, please visit USAMRAA’s Full Funding Opportunity Announcement.

 

USAMRAA: DoD FY15 Reconstructive Transplant Research (RTR) Translational Research Award

Funding Opportunity Number: W81XWH-15-RTR-TRA

To meet the intent of the FY15 RTR award mechanisms, applicants must address one or more of the Focus Areas listed below. Immune system regulation, Improved access to reconstructive transplantation , Reconstructive transplantation rehabilitation, Graft surveillance – Clinical monitoring, Psychosocial issues associated with VCA. The RTR Translational Research Award (RTR TRA) mechanism is being offered for the first time in FY15. The intent of the FY15 RTR TRA mechanism is to support the development of data and model systems to complete the Food and Drug Administration (FDA) regulatory review process and position the product for a clinical trial. Applications must include preliminary and/or published data that is relevant to RTR and the proposed research project. Observations that drive a research idea may be derived from many sources, such as a laboratory discovery, population-based studies, or a clinician’s firsthand knowledge of patients and anecdotal data. This funding opportunity was announced on July 23, 2015. The application deadline is December 1, 2015. For more information, please visit USAMRAA’s Full Funding Opportunity Announcement.

 

USAMRAA: DoD FY15 Reconstructive Transplant Research (RTR) Idea Discovery Award

Funding Opportunity Number: W81XWH-15-RTR-IDA

To meet the intent of the FY15 RTR award mechanisms, applicants must address one or more of the Focus Areas listed below. Immune system regulation, Improved access to reconstructive transplantation , Reconstructive transplantation rehabilitation, Graft surveillance – Clinical monitoring, Psychosocial issues associated with VCA.The RTR Idea Discovery Award (RTR IDA) mechanism is being offered for the first time in FY15. The intent of the RTR IDA is to support innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods relevant to RT. Studies supported by this award are expected to develop robust data that will lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The Idea Discovery Award is not intended to support a logical progression of an already established research project. The proposed research project should be novel and innovative. Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities. Research that is an incremental advance upon published data is not considered innovative and will not be considered for funding under this award mechanism. This funding opportunity was announced on July 23, 2015. The application deadline is October 14, 2015. For more information, please visit USAMRAA’s Full Funding Opportunity Announcement.

 

USAMRAA: DoD FY15 Reconstructive Transplant Research (RTR) Concept Award

Funding Opportunity Number: W81XWH-15-RTR-CA

To meet the intent of the FY15 RTR award mechanisms, applicants must address one or more of the Focus Areas listed below. Immune system regulation, Improved access to reconstructive transplantation , Reconstructive transplantation rehabilitation, Graft surveillance – Clinical monitoring, Psychosocial issues associated with VCA. The RTR Concept Award (RTR CA) mechanism is being offered for the first time in FY15. The intent of the RTR CA is to support the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to RT. The Concept Award is not intended to support a logical progression of an already established research project but, instead, supports high-risk studies that have the potential to reveal entirely new avenues for investigation. This funding opportunity was announced on July 23, 2015. The application deadline is October 14, 2015. For more information, please visit USAMRAA’s Full Funding Opportunity Announcement.

 

USAMRAA: DoD Breast Cancer Breakthrough Award Level 3 Award

Funding Opportunity Number: W81XWH-15-BCRP-BREAKTHROUGH2-FL3

The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. The critical components of this award mechanism are: Impact: Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The impact may be near-term or long-term, but must be significant and move beyond an incremental advancement. Applications must articulate the pathway to making a clinical impact for individuals with, or at risk for, breast cancer, even if clinical impact is not an immediate outcome. Research Scope: Research proposed under this award mechanism may be small- to large-scale projects, at different stages of idea and research development. One funding level, based on the scope of the research, is available under this Program Announcement. Two additional funding levels, Funding Levels 1 and 2, will be available under a different Program Announcement in August 2015. This funding opportunity was announced on July 23, 2015. The application deadline is December 21, 2015. For more information, please visit USAMRAA’s Full Funding Opportunity Announcement.

 

NIH Funding Opportunity Announcements:

 

NIH: Occupational Safety and Health Education and Research Centers (T42)

Funding Opportunity Number: PAR-15-303

The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), invites grant applications for funding Education and Research Centers (ERCs) that are focused on occupational safety and health training, research training, education and outreach. NIOSH is mandated to provide an adequate supply of qualified personnel to carry out the purposes of the Occupational Safety and Health Act, and the ERCs are one of the principal means for meeting this mandate. ERCs are academic institutions that provide high-quality interdisciplinary graduate training, research training, continuing education, and outreach in the core occupational safety and health disciplines of industrial hygiene (IH), occupational health nursing (OHN), occupational medicine residency (OMR), and occupational safety (OS), as well as closely related allied disciplines. Research and research training are integral components of ERCs, with ERC faculty and NIOSH trainees conducting research on issues related to the NIOSH National Occupational Research Agenda (NORA). The ERCs also serve as regional resources for industry, labor, government, and the public. This funding opportunity was announced on July 21, 2015. A letter of intent is due October 2, 2015. The initial application deadline is December 3, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Clinical and Translational Science Award (U54)

Funding Opportunity Number: PAR-15-304

The purpose of this funding opportunity announcement (FOA) is to invite applications to participate in the Clinical and Translational Science Award (CTSA) program which supports high quality translational and clinical research locally, regionally and nationally and fosters innovation in research methods, training, and career development. The following goals for the CTSA program in an ideal state: 1. Workforce Development: the translational science workforce has the skills and knowledge necessary to advance translation of discoveries 2. Collaboration/Engagement: Stakeholders are engaged in collaborations to advance translation 3. Integration - Translational science is integrated across its multiple phases and disciplines within complex populations and across the individual lifespan. 4. Methods/Processes - The scientific study of the process of conducting translational science itself enables significant advances in translation. 5. Informatics – Innovative informatics solutions are used to advance translational research, train the CTSA workforce, disseminate best practices, engage communities of the stakeholders, and integrate clinical and basic research data. This funding opportunity was announced on July 23, 2015. A letter of intent is due 30 days prior to the application deadline. The initial application deadline is  September 25, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: GenitoUrinary Development Molecular Anatomy Project (GUDMAP) - Human Tissue Core (U24)

Funding Opportunity Number: RFA-DK-15-016

This Funding Opportunity Announcement requests applications for a Human Tissue Core for the GenitoUrinary Development Molecular Anatomy Project (GUDMAP) consortium. The Human Tissue Core will identify and manage tissue source site(s), ensure tissue quality, and distribute human kidney and lower urinary tract samples to the Atlas Project sites. The GUDMAP consortium has established a molecular anatomy atlas of the developing murine kidney and the lower urinary tract. In this new reiteration of GUDMAP, human data will be generated and incorporated into the GUDMAP database. The fundamental information provided by GUDMAP will serve as a baseline for developing new strategies for repair or replacement of damaged organs, for understanding organogenesis and the etiology of congenital malformations, and for generating insights into pathologic processes underlying developmental defects and disease. This funding opportunity was announced on July 23, 2015. A letter of intent is due October 9, 2015. The application deadline is November 9, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: GenitoUrinary Development Molecular Anatomy Project (GUDMAP) - Database/Website Project (U24)

Funding Opportunity Number: RFA-DK-15-015

In this Funding Opportunity Announcement, applications are invited for a data coordinating center for the GenitoUrinary Development Molecular Anatomy Project (GUDMAP) consortium. The GUDMAP consortium has established a molecular anatomy atlas of the developing murine kidney and the lower urinary tract. The fundamental information provided by GUDMAP serves as a baseline for planning new strategies for repair or replacement of damaged organs, for understanding organogenesis and the etiology of congenital malformations, and for generating insights into pathologic processes underlying developmental defects and disease. This funding opportunity was announced on July 23, 2015. A letter of intent is due October 9, 2015. The application deadline is November 9, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: GenitoUrinary Development Molecular Anatomy Project (GUDMAP) - Atlas Projects (U01)

Funding Opportunity Number: RFA-DK-15-014

This Funding Opportunity Announcement requests applications for GUDMAP Atlas Projects to generate data for the GUDMAP database. The scope of Atlas projects is limited to either human or murine studies. The interrogation of human tissue is limited to normal developing tissues of the kidney or lower urinary tract.Murine studies may include the molecular anatomy of the innervation and vasculature of the kidney, as well as lower urinary tract organs. Furthermore, murine studies may include the interrogation of well-chosen sets of murine developmental diseases or defects of the kidney and lower urinary tract. This funding opportunity was announced on July 23, 2015. A letter of intent is due October 9, 2015. The application deadline is November 9, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Big Data to Knowledge (BD2K) Development of Software Tools and Methods for Biomedical Big Data

Funding Opportunity Number: RFA-CA-15-017

The purpose of this BD2K Funding Opportunity Announcement (FOA) is to solicit development of software tools and methods in the three topic areas of data privacy, data repurposing, and applying metadata, all as part of the overall BD2K initiative. While this FOA is intended to foster new development, submissions consisting of significant adaptations of existing methods and software are also invited. This funding opportunity was announced on July 23, 2015. A letter of intent is due September 6, 2015. The application deadline is October 6, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention R01, R21, & U01

Funding Opportunity Number: PAR-15-308 (R01) PAR-15-309 (R21) PAR-15-307 (U01)

This Funding Opportunity Announcement (FOA), encourages research projects focused on adducts to cellular macromolecules as indicators of exposures to cancer risk factors relevant to human populations. The priority is on projects that will focus on adductomic approaches, i.e., address some aspects of the totality of adducts. These projects should explore the basic aspects of adducts/adductomics that may have a potential utility in cancer detection, cancer prevention, and/or assessing cancer risks. The projects should be relevant to adducts in humans and human populations but may be conducted using various model systems (e.g., cultured cells, animals, etc.). The use of human biospecimens is encouraged and expected if appropriate but not required. A R01 grant supports a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. A R21 grant encourages the development of new research activities in categorical program areas. (Support generally is restricted in level of support and in time.) A U01 grant supports a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. These funding opportunities were announced on July 24, 2015. A letter of intent is due October 23, 2015 for all three grant types. The initial application deadline for all three grant types is November 23, 2015. For more information, please visit NIH's Full Funding Opportunity Announcements (R01, R21 and U01).

 

NIH: Lymphatics in Health and Disease in the Digestive System, Kidney, and Urinary Tract (R01)

Funding Opportunity Number: PAR-15-306

This FOA is to encourage Research Project Grant (R01) applications for research into aspects of lymphatic vessel physiology, development and pathophysiology related to health and diseases of the digestive system, kidney, and urinary tract organs. However, studies with the major focus on immune mechanisms are not encouraged. Studies to understand the factors that control local lymphatic vessel functional anatomy and physiology and development during health or disease in these organs/systems, and the mechanisms by which alterations of lymphatic vessel function affect organ function, are of interest. This funding opportunity was announced on July 24, 2015. The initial application deadline is October 5, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival R01 & R21

Funding Opportunity Numbers: PA-15-311 (R01) & PA-15-310 (R21)

This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previous animal or observational research on established biomarkers other than insulin/glucose metabolism, especially those obtained from tumor tissue sourced from repeat biopsies where available. Because many cancer survivor populations will not experience recurrence but will die of comorbid diseases or may experience early effects of aging, inclusion of biomarkers of comorbid diseases (e.g., cardiovascular disease) and of the aging process are also sought. Applications should use experimental designs (e.g., randomized controlled clinical trials (RCTs), fractional factorial designs), and will require transdisciplinary approaches that bring together behavioral intervention expertise, cancer biology, and other basic and clinical science disciplines relevant to the pathways being studied. A R01 grant supports a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. A R21 grant encourages the development of new research activities in categorical program areas. These funding opportunities were announced on July 24, 2015. The initial application deadline for the R01 is October 5, 2015 and for the R21 is October 16, 2015. For more information, please visit NIH's Full Funding Opportunity Announcements (R01 & R21).


Association Management Software Powered by YourMembership  ::  Legal